U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
FARLETUZUMAB
INN   MART.   USAN   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER
Common Name English
FARLETUZUMAB [USAN]
Common Name English
FARLETUZUMAB [JAN]
Common Name English
MORAB-003
Code English
Farletuzumab [WHO-DD]
Common Name English
FARLETUZUMAB [MART.]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER
Common Name English
farletuzumab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 204905
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
NCI_THESAURUS C20401
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
Code System Code Type Description
DRUG BANK
DB05595
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
NCI_THESAURUS
C61503
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
USAN
TT-118
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
CAS
896723-44-7
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
ChEMBL
CHEMBL1743016
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
EVMPD
SUB33728
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
INN
9067
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
FDA UNII
2O09BG0OWA
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
WIKIPEDIA
FARLETUZUMAB
Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023
PRIMARY
ACTIVE MOIETY
FARLETUZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966